Type:
Educational Exhibit
Keywords:
Tissue characterisation, Metastases, Cancer, Diagnostic procedure, PET-CT, Oncology, Nuclear medicine, Molecular imaging
Authors:
R. N. Jayan1, L. O'Mahony1, E. Mulvihill1, R. A. fernando2, N. Seshadri2, R. S. Dwarkanath2, E. Ahmed1; 1Liverpool/UK, 2Liverpool /UK
DOI:
10.26044/ecr2019/C-2849
References
1Cancer Research UK.
[No date].
Cancer of unknown primary statistics. [Online].
[Accessed December 2018].
Available from: https://www.cancerresearchuk.org.
2 National institute for Heath and Care Excellence.
2010.
Metastatic malignant disease of unknown primary origin in adults: diagnosis and management.
[CG104].
[Online].
London: National institute for Heath and Care Excellence.
[Accessed December 2018].
Available from: https://www.nice.org.uk/guidance/cg104/chapter/1-Guidance#diagnosis.
3Ettinger DS,
Agulnik M,
Cates JM,
et al.
NCCN clinical practice guidelines in oncology: occult primary.
J Natl Compr Cancer Netw.
2011;9:1358-95.
4Cetin Avci N,
Hatipoglu F,
Alacacaioglu A,
Bayar EE,
Bural GG.
FDG PET/CT and Conventional Imaging Method in Cancer of Unknown Primary: an Approach to Overscanning.
Nucl Med Mol Imaging.
2018;52(6):438-444.
5Burglin SA,
Hess S,
Høilund-Carlsen PF,
Gerke O.
18F-FDG PET/CT for detection of the primary tumour in adults with extracervical metastases from cancer of unknown: A systematic review and meta-anaylsis.
Medicine (Baltimore).
2017 Apr;96(16):e6713.
6Moller AK,
Loft A,
Berthelsen AK,
Damgaard Pedersen K,
Graff J,
Christensen CB et al. 18F-FDG PET/CT as a diagnostic tool in patients with extracervical carcinoma of unknown primary site: a literature review.
Oncologist.
2011;16(4):445-51.